📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer. (2015)

First Author: Nestal De Moraes G

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/oncsis.2015.26

PubMed Identifier: 26344694

Publication URI: http://europepmc.org/abstract/MED/26344694

Type: Journal Article/Review

Volume: 4

Parent Publication: Oncogenesis

Issue: 9

ISSN: 2157-9024